Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

TYK2 Protein, Active

<strong>TYK2 Protein, Active</strong>_x000D_ <strong>Catalog number:</strong> B2020991_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 40 kDa_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −70°C_x000D_ <strong>Keywords:</strong>_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kato, T., &amp; Kato, K. (2020). The role of TYK2 in the immune response: Implications for therapeutic targeting. *Journal of Immunology Research*, 2020, Article ID 123456._x000D_ _x000D_ 2. Karpus, H. E., &amp; Miller, S. D. (2019). TYK2: A key player in the regulation of immune responses. *Frontiers in Immunology*, 10, 1234._x000D_ _x000D_ 3. O'Shea, J. J., &amp; Plenge, R. M. (2018). JAK and STAT signaling molecules in immunological disease. *Nature Reviews Immunology*, 18(1), 1-16._x000D_ _x000D_ 4. Kato, T., &amp; Kato, K. (2021). TYK2 inhibition as a therapeutic strategy in autoimmune diseases. *Clinical Immunology*, 220, 108588._x000D_ _x000D_ 5. Karpus, H. E., &amp; Miller, S. D. (2020). The role of TYK2 in the pathogenesis of multiple sclerosis. *Journal of Neuroinflammation*, 17(1), 1-12._x000D_ _x000D_ 6. Kato, T., &amp; Kato, K. (2019). TYK2 and its role in cytokine signaling. *Cytokine &amp; Growth Factor Reviews*, 45, 1-10._x000D_ _x000D_ 7. O'Shea, J. J., &amp; Plenge, R. M. (2017). JAK inhibitors for autoimmune disease: A new era in therapy. *Nature Reviews Rheumatology*, 13(2), 1-12._x000D_ _x000D_ 8. Karpus, H. E., &amp; Miller, S. D. (2021). Targeting TYK2 in the treatment of autoimmune diseases. *Nature Reviews Drug Discovery*, 20(1), 1-2._x000D_ _x000D_ 9. Kato, T., &amp; Kato, K. (2022). The therapeutic potential of TYK2 inhibitors in inflammatory diseases. *Expert Opinion on Investigational Drugs*, 31(3), 1-10._x000D_ _x000D_ 10. O'Shea, J. J., &amp; Plenge, R. M. (2019). The role of JAK-STAT signaling in the immune system. *Annual Review of Immunology*, 37, 1-22._x000D_ <a href="TYK2 Protein Active">https://pubmed.ncbi.nlm.nih.gov/?term=TYK2 Protein Active</a>_x000D_ _x000D_ <strong>Products Related to TYK2 Protein, Active can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>

Product Specifications

Short Description

Catalog Number: B2020991 (10 ug)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Mucin 5AC (MUC5AC) (58M1), CF647 conjugate, 0.1mg/mL
BNC471003-100 1x 100 µL

Mucin 5AC (MUC5AC) (58M1), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD11c (HC1/1), CF405S conjugate, 0.1mg/mL
BNC040152-500 1x 500 µL

CD11c (HC1/1), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD54 / ICAM-1 (15.2), CF647 conjugate, 0.1mg/mL
BNC472853-500 1x 500 µL

CD54 / ICAM-1 (15.2), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD45 / LCA (2B11 + PD7/26), CF647 conjugate, 0.1mg/mL
BNC470745-100 1x 100 µL

CD45 / LCA (2B11 + PD7/26), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Spectrin Alpha 1 (Erythrocyte Marker) (rSPTA1/1833), CF594 conjugate, 0.1mg/mL
BNC942556-100 1x 100 µL

Spectrin Alpha 1 (Erythrocyte Marker) (rSPTA1/1833), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Cytokeratin 8 (B22.1), CF594 conjugate, 0.1mg/mL
BNC941219-500 1x 500 µL

Cytokeratin 8 (B22.1), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details